» Articles » PMID: 6804309

Long-term Follow-up of Acute and Chronic Non-A, Non-B Post-transfusion Hepatitis: Evidence of Progression to Liver Cirrhosis

Overview
Journal Gut
Specialty Gastroenterology
Date 1982 Apr 1
PMID 6804309
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The long-term outcome of non-A, non-B post-transfusion hepatitis was evaluated in 21 patients who developed the illness after open-heart surgery and could be followed thereafter up to five years. Histological chronic sequelae were documented in 13 patients, and consisted of chronic persistent hepatitis in one case, chronic lobular hepatitis in two and chronic active hepatitis in 10, five of whom also developed superimposed cirrhosis. Progression to these chronic states was in most cases symptomless, independently of the severity of liver lesions; one patient, however, died of gastrointestinal bleeding due to cirrhosis of the liver. During follow-up the biochemical pattern of chronic non-A, non-B hepatitis was unique, while striking fluctuations of transaminase levels. Liver histology proved essential to identify the severity of chronic liver lesions, as clinical and biochemical features were uniform and not indicative of it. Our results suggest that cirrhosis may develop, often with an asymptomatic course, in a significant number of patients who do not recover after acute post-transfusion non-A, non-B hepatitis.

Citing Articles

Breakthroughs in hepatitis C research: from discovery to cure.

Manns M, Maasoumy B Nat Rev Gastroenterol Hepatol. 2022; 19(8):533-550.

PMID: 35595834 PMC: 9122245. DOI: 10.1038/s41575-022-00608-8.


Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C.

Bresci G, Parisi G, Metrangolo S, Bertoni M, Capria A Clin Drug Investig. 2008; 15(4):271-7.

PMID: 18370481 DOI: 10.2165/00044011-199815040-00002.


Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Hayashi J, Kashiwagi S Drugs Aging. 1997; 11(4):296-308.

PMID: 9342559 DOI: 10.2165/00002512-199711040-00005.


Patterns of progression: unpredictability and risk of decompensated cirrhosis.

Tassopoulos N Dig Dis Sci. 1996; 41(12 Suppl):41S-48S.

PMID: 9011475 DOI: 10.1007/BF02087875.


Interferon as treatment for acute hepatitis C. A meta-analysis.

Camma C, Almasio P, Craxi A Dig Dis Sci. 1996; 41(6):1248-55.

PMID: 8654160 DOI: 10.1007/BF02088245.


References
1.
De Groote J, Desmet V, GEDIGK P, KORB G, Popper H, POULSEN H . A classification of chronic hepatitis. Lancet. 1968; 2(7568):626-8. DOI: 10.1016/s0140-6736(68)90710-1. View

2.
. Morphological criteria in viral hepatitis. Review by an international group. Lancet. 1971; 1(7694):333-7. View

3.
Popper H, Schaffner F . The vocabulary of chronic hepatitis. N Engl J Med. 1971; 284(20):1154-6. DOI: 10.1056/NEJM197105202842011. View

4.
Koretz R, Suffin S, Gitnick G . Post-transfusion chronic liver disease. Gastroenterology. 1976; 71(5):797-803. View

5.
Knodell R, CONRAD M, Ishak K . Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology. 1977; 72(5 Pt 1):902-9. View